Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations (2009)

  • Authors:
  • USP affiliated authors: CARRASCO, SOLANGE - FM ; SOUZA, ROMY BEATRIZ CHRISTMANN DE - FM ; SCHAINBERG, CLAUDIA GOLDENSTEIN - FM
  • USP Schools: FM; FM; FM
  • DOI: 10.1007/s10067-009-1124-0
  • Subjects: MOLÉCULAS DE ADESÃO CELULAR; SISTÊMICO ESCLERODERMA (ESTUDO CLÍNICO)
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s10067-009-1124-0 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Clinical Rheumatology

    ISSN: 0770-3198

    Citescore - 2017: 2.04

    SJR - 2017: 0.93

    SNIP - 2017: 0.877


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM10700094217-SFM BCBIB
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SAWAYA, Heloisa Helena Braga; SOUZA, Romy Beatriz Christmann; CARRASCO, Solange; SCHAINBERG, Claudia Goldenstein. Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations. Clinical rheumatology, London, v. 28, n. 7, p. 801-805, 2009. DOI: 10.1007/s10067-009-1124-0.
    • APA

      Sawaya, H. H. B., Souza, R. B. C., Carrasco, S., & Schainberg, C. G. (2009). Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations. Clinical rheumatology, 28( 7), 801-805. doi:10.1007/s10067-009-1124-0
    • NLM

      Sawaya HHB, Souza RBC, Carrasco S, Schainberg CG. Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations. Clinical rheumatology. 2009 ; 28( 7): 801-805.
    • Vancouver

      Sawaya HHB, Souza RBC, Carrasco S, Schainberg CG. Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations. Clinical rheumatology. 2009 ; 28( 7): 801-805.

    Referências citadas na obra
    Pigot R, Power C (1993) The adhesion molecule facts book. Academic, San Diego
    Ley K, Tedder TF (1995) Leukocyte interactions with vascular endothelium. New insights into selectin-mediated attachment and rolling. J Immunol 155:525–528
    Ihn H, Fujimoto M, Sato S, Kikuchi K, Igarashi A, Soma Y et al (1994) Increased levels of circulation intercellular adhesion molecule-1 in patients with localized scleroderma. J Am Acad Dermatol 31:591–595
    Ihn H, Sato S, Kikuchi K, Fujimoto M, Takehara K (1995) Demonstration of interleukin-2, interleukin-4, and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res 287:193–197
    Ihn H, Sato S, Kikuchi K, Fujimoto M, Takehara K (1994) Demonstration of interleukin-8 in serum samples of patients with localized scleroderma. Arch Dermatol 130:1327–1328
    Hasegawa M, Sato T, Takehara K (1999) Augmented production of chemokines (MCP-1, MIP-1α, and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis. Clin Exp Immunol 117:503–507
    Solberg S, Peltonen J, Uitto J, Jimenez SA (1992) Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset. Arthritis Rheum 35:290–298
    Gruschwitz MS, Hornstein OP, von den Driesch P (1995) Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 38:184–189
    Gruschwitz MS, Hornstein OP, von den Driesch P et al (1992) Expression of adhesion proteins involved in cell–cell and cell–matrix interactions in the skin of patients with progressive systemic sclerosis. J Am Acad Dermatol 27:169–177
    Majewski S, Hunzelmann N, Johnson JP et al (1991) Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma. J Invest Dermatol 97:667–671
    Shi-Wen X, Panesar M, Vancheeswaran R et al (1994) Expression and shedding of intercellular adhesion molecule1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Arthritis Rheum 37:1689–1697
    Shimada Y, Hasegawa M, Takehara K, Sato S (2001) Elevated serum l-selectin levels and decreased l-selectin expression on CD8+ lymphocytes in systemic sclerosis. Clin Exp Immunol 124:474–479
    Ates A, Kinikli G, Turgay M, Duman M (2004) Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis. Scand J Immunol 59:315–320
    Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S (2005) Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol 24:111–116
    Masi AT, Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581–590
    LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205
    Böyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97:77–89
    Mitri GM, Lucas M, Fertig N, Steen VD, Medsger TA Jr (2003) A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 48(1):203–209
    Ihn H, Sato S, Fujimoto M, Kikuchi K, Kadono T, Tamaki K, Takahera K (1997) Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines. Br J Rheumatol 36:1270–1275
    Moffatt OD, Devitt A, Bell ED, Simmons DL, Gregory CD (1999) Macrophage recognition of ICAM-3 on apoptotic leukocytes. J Immunol 162:800–810
    De Fougerolles AR, Springer TA (1992) Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med 175:185–190
    De Fougerolles AR, Diamond MS, Springer TA (1993) Cloning and expression of intercellular adhesion molecule 3 reveals strong homology to other immunoglobulin family counter-receptors for lymphocyte function-associated antigen. J Exp Med 177:1187–1192
    Walcheck B, Kahn J, Fisher JM, Wang BB, Fisk RS, Payan DG, Feehan C, Betageri R, Darlak K, Spatola AF, Kishimoto TK (1996) Neutrophil rolling altered by inhibition of l-selectin shedding in vitro. Nature 380:720–723
    Chen A, Engel P, Tedder TF (1995) Structural requirements regulate endoproteolytic release of the l-selectin (CD62L) adhesion receptor from the cell surface of leukocytes. J Exp Med 182:519–530
    Blann AD, Sanders PA, Herrick A, Jayson MI (1996) Soluble l-selectin in the connective tissue diseases. Br J Haematol 95:192–194
    Nicolls MR, Gill RG (2006) LFA-1 (CD11a) as a therapeutic target. Am J Transplant 6:26–36